Stalicla Competitors and Similar CompaniesClear all
Stalicla's competitors and similar companies include Holobiome, Neurim Pharmaceuticals, Alector and Supernus Pharmaceuticals.
 Stalicla Stalicla is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders. |  Holobiome Holobiome is a biotechnology company developing microbiome-based therapeutics for mental health. |  Neurim Pharmaceuticals Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 1991 | Founding Date 2013 | Founding Date 2005 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Genève, CH HQ | Locations Cambridge, US HQ | Locations Tel Aviv-Yafo, IL HQ Zug, CH | Locations San Francisco, US HQ | Locations Rockville, US HQ |
Employees | Employees 264% increase | Employees 148% increase | Employees 20 | Employees 2382% decrease | Employees 6527% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 495.3 m | Valuation ($) 1.9 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $21m (FY, 2025) | Revenue (est.) $719m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($142.9m) (FY, 2025) | Net income ($38.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 8m (over 6 years ago) | Latest funding round $ 299.7k (almost 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 18.2m | Total funding raised $ 1m | Total funding raised N/A | Total funding raised $ 194.5m | Total funding raised $ 69.5m |
For sources of this data, please see the company profile
View Company Profiles
Holobiome
HQ
Cambridge, US
Employees
14↑ 8% increase
Holobiome is a biotechnology company developing microbiome-based therapeutics for mental health.
View companyNeurim Pharmaceuticals
HQ
Tel Aviv-Yafo, IL
Employees
20
Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders.
View companyAlector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View companySupernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View company